Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $627.43 | 31 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $170.59 | 8 | $0 (2023) |
| Daiichi Sankyo Inc. | $105.00 | 5 | $0 (2023) |
| ABBVIE INC. | $72.61 | 4 | $0 (2024) |
| Exeltis, USA Inc. | $50.31 | 3 | $0 (2024) |
| MAYNE PHARMA COMMERCIAL LLC | $35.17 | 2 | $0 (2023) |
| Astellas Pharma US Inc | $34.35 | 1 | $0 (2024) |
| Merck Sharp & Dohme LLC | $33.34 | 2 | $0 (2023) |
| Pacira Pharmaceuticals Incorporated | $33.29 | 1 | $0 (2023) |
| Takeda Pharmaceuticals U.S.A., Inc. | $30.62 | 1 | $0 (2023) |
| PFIZER INC. | $26.11 | 2 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $99.16 | 4 | Astellas Pharma US Inc ($34.35) |
| 2023 | $366.30 | 18 | Novo Nordisk Inc ($130.89) |
| 2022 | $101.72 | 5 | Daiichi Sankyo Inc. ($46.22) |
| 2021 | $60.25 | 4 | AbbVie Inc. ($31.74) |
All Payment Transactions
31 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/09/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $34.35 | General |
| Category: Biological | ||||||
| 05/17/2024 | ABBVIE INC. | LO LOESTRIN FE (Drug) | Food and Beverage | In-kind items and services | $25.53 | General |
| Category: WOMENS HEALTH | ||||||
| 02/13/2024 | Exeltis, USA Inc. | SLYND (Drug) | Food and Beverage | In-kind items and services | $20.60 | General |
| Category: CONTRACEPTIVE | ||||||
| 02/07/2024 | Axonics, Inc. | Axonics (Device) | Food and Beverage | In-kind items and services | $18.68 | General |
| Category: Urology | ||||||
| 09/23/2023 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $23.79 | General |
| Category: Obesity | ||||||
| 07/24/2023 | Shield Therapeutics Inc | ACCRUFER (Drug) | Food and Beverage | In-kind items and services | $17.36 | General |
| Category: Hematology | ||||||
| 07/10/2023 | PFIZER INC. | MYFEMBREE (Drug) | Food and Beverage | In-kind items and services | $14.44 | General |
| Category: GENITOURINARY (SEXUAL HEALTH);WOMENS HEALTH | ||||||
| 06/28/2023 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $23.16 | General |
| Category: Obesity | ||||||
| 06/23/2023 | Pacira Pharmaceuticals Incorporated | Exparel (Drug) | Food and Beverage | In-kind items and services | $33.29 | General |
| Category: Pain Management | ||||||
| 05/02/2023 | MAYNE PHARMA COMMERCIAL LLC | — | Food and Beverage | In-kind items and services | $16.73 | General |
| 04/24/2023 | Exeltis, USA Inc. | SLYND (Drug) | Food and Beverage | In-kind items and services | $14.59 | General |
| Category: Oral Contraceptive | ||||||
| 04/11/2023 | MAYNE PHARMA COMMERCIAL LLC | — | Food and Beverage | In-kind items and services | $18.44 | General |
| 04/04/2023 | Novo Nordisk Inc | Wegovy (Drug), Saxenda | Food and Beverage | In-kind items and services | $19.65 | General |
| Category: Obesity | ||||||
| 03/23/2023 | Novo Nordisk Inc | Wegovy (Drug), Saxenda | Food and Beverage | In-kind items and services | $19.42 | General |
| Category: Obesity | ||||||
| 03/08/2023 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $20.45 | General |
| Category: Iron Deficiency Anemia | ||||||
| 03/06/2023 | Merck Sharp & Dohme LLC | GARDASIL 9 (Biological) | Food and Beverage | In-kind items and services | $17.54 | General |
| Category: VACCINE | ||||||
| 02/09/2023 | Novo Nordisk Inc | Wegovy (Drug), Saxenda | Food and Beverage | In-kind items and services | $21.03 | General |
| Category: Obesity | ||||||
| 01/31/2023 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $15.34 | General |
| Category: NEUROSCIENCE | ||||||
| 01/31/2023 | Exeltis, USA Inc. | SLYND (Drug) | Food and Beverage | In-kind items and services | $15.12 | General |
| Category: Oral Contraceptive | ||||||
| 01/25/2023 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $30.62 | General |
| Category: NEUROSCIENCE | ||||||
| 01/17/2023 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $21.49 | General |
| Category: Iron Deficiency Anemia | ||||||
| 01/04/2023 | Novo Nordisk Inc | Saxenda (Drug), Wegovy | Food and Beverage | In-kind items and services | $23.84 | General |
| Category: Obesity | ||||||
| 08/30/2022 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $23.45 | General |
| Category: Iron Deficiency Anemia | ||||||
| 08/23/2022 | Novo Nordisk Inc | Saxenda (Drug) | Food and Beverage | In-kind items and services | $20.24 | General |
| Category: Obesity | ||||||
| 06/15/2022 | Merck Sharp & Dohme LLC | GARDASIL 9 (Biological) | Food and Beverage | In-kind items and services | $15.80 | General |
| Category: VACCINE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 431 | 488 | $33,115 | $13,355 |
| 2022 | 6 | 500 | 567 | $34,706 | $14,300 |
| 2021 | 8 | 535 | 650 | $42,684 | $17,637 |
| 2020 | 7 | 500 | 603 | $52,503 | $21,412 |
All Medicare Procedures & Services
27 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 66 | 114 | $15,162 | $5,432 | 35.8% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2023 | 124 | 124 | $9,052 | $3,753 | 41.5% |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | Office | 2023 | 105 | 105 | $6,300 | $3,529 | 56.0% |
| 82270 | Stool analysis for blood to screen for colon tumors | Office | 2023 | 97 | 97 | $1,649 | $416.13 | 25.2% |
| 87210 | Smear for infectious agents | Office | 2023 | 17 | 22 | $484.00 | $125.40 | 25.9% |
| 81000 | Manual urinalysis test with examination using microscope, non-automated | Office | 2023 | 22 | 26 | $468.00 | $99.35 | 21.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 52 | 100 | $13,300 | $4,898 | 36.8% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2022 | 147 | 147 | $10,731 | $4,529 | 42.2% |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | Office | 2022 | 117 | 117 | $7,020 | $3,966 | 56.5% |
| 82270 | Stool analysis for blood to screen for colon tumors | Office | 2022 | 131 | 131 | $2,227 | $565.52 | 25.4% |
| 87210 | Smear for infectious agents | Office | 2022 | 25 | 33 | $726.00 | $189.42 | 26.1% |
| 81000 | Manual urinalysis test with examination using microscope, non-automated | Office | 2022 | 28 | 39 | $702.00 | $151.68 | 21.6% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 64 | 152 | $20,216 | $7,901 | 39.1% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2021 | 145 | 145 | $10,585 | $4,522 | 42.7% |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | Office | 2021 | 112 | 112 | $6,720 | $3,858 | 57.4% |
| 82270 | Stool analysis for blood to screen for colon tumors | Office | 2021 | 114 | 114 | $1,938 | $499.32 | 25.8% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 12 | 12 | $924.00 | $326.25 | 35.3% |
| 87210 | Smear for infectious agents | Office | 2021 | 39 | 48 | $1,056 | $279.36 | 26.5% |
| 81000 | Manual urinalysis test with examination using microscope, non-automated | Office | 2021 | 37 | 54 | $972.00 | $217.08 | 22.3% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2021 | 12 | 13 | $273.00 | $34.00 | 12.5% |
| 77067 | Mammography of both breasts | Office | 2020 | 82 | 82 | $14,842 | $7,389 | 49.8% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 71 | 154 | $20,482 | $6,321 | 30.9% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2020 | 125 | 125 | $9,125 | $3,986 | 43.7% |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | Office | 2020 | 88 | 88 | $5,280 | $3,031 | 57.4% |
| 82270 | Stool analysis for blood to screen for colon tumors | Office | 2020 | 90 | 90 | $1,530 | $391.77 | 25.6% |
About Melissa Reeves, APN
Melissa Reeves, APN is a Family healthcare provider based in Union City, Tennessee. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/21/2011. The National Provider Identifier (NPI) number assigned to this provider is 1801193297.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Melissa Reeves, APN has received a total of $627.43 in payments from pharmaceutical and medical device companies, with $99.16 received in 2024. These payments were reported across 31 transactions from 12 companies. The most common payment nature is "Food and Beverage" ($627.43).
As a Medicare-enrolled provider, Reeves has provided services to 1,966 Medicare beneficiaries, totaling 2,308 services with total Medicare billing of $66,704. Data is available for 4 years (2020–2023), covering 27 distinct procedure/service records.
Practice Information
- Specialty Family
- Location Union City, TN
- Active Since 02/21/2011
- Last Updated 04/05/2024
- Taxonomy Code 363LF0000X
- Entity Type Individual
- NPI Number 1801193297
Products in Payments
- Wegovy (Drug) $107.05
- INJECTAFER (Drug) $105.00
- Saxenda (Drug) $63.54
- SLYND (Drug) $50.31
- LO LOESTRIN FE (Drug) $44.71
- Veozah (Drug) $34.35
- GARDASIL 9 (Biological) $33.34
- Exparel (Drug) $33.29
- TRINTELLIX (Drug) $30.62
- UBRELVY (Drug) $27.90
- Axonics (Device) $18.68
- ACCRUFER (Drug) $17.36
- MYFEMBREE (Drug) $14.44
- PREMARIN (Drug) $11.67
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Union City
Yanet Rivas
Family — Payments: $10,797
Laura Russell, Cfnp, CFNP
Family — Payments: $5,430
Ms. Bernadette Ramos, Apn, APN
Family — Payments: $5,151
Brenda Dexter, Fnp C, FNP C
Family — Payments: $4,920
Amy Myers, Cfnp, CFNP
Family — Payments: $4,698
Rita Koon, Fnp Bc, FNP BC
Family — Payments: $3,936